SCHEMBL19219084

SCHEMBL19219084

c1ccc(-c2cc(-c3ccc(-c4ccncc4)cc3)ncn2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.60
ASIC3 Q9UHC3 2/20 0.55
MIF P14174 1/20 0.55
KMO O15229 3/20 0.50
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
PIK3CA P42336 1/20 0.47
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 1/20 0.46
AR P10275 1/20 0.46
MKNK1 Q9BUB5 1/20 0.45
TSHR P16473 1/20 0.45
RECQL P46063 1/20 0.45
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
DHODH Q02127 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18905236 0.96 ASIC3 (0.59) NOTUMASIC3MIFKMONPC1
SCHEMBL22376007 0.94 NOTUM (0.54) NOTUMASIC3MIFKMONPC1
SCHEMBL17694984 0.92 MAPT (0.52) NOTUMASIC3MIFSMN1; SMN2LMNA
SCHEMBL17694993 0.92 MAPT (0.52) NOTUMASIC3MIFSMN1; SMN2LMNA
SCHEMBL18731738 0.89 ASIC3 (0.65) ASIC3MIFKMONPC1RAB9A
SCHEMBL17697185 0.89 ASIC3 (0.65) ASIC3MIFKMONPC1RAB9A
SCHEMBL29730373 0.89 ASIC3 (0.65) ASIC3MIFKMONPC1RAB9A
SCHEMBL17694991 0.87 ABL1 (0.50) NOTUMASIC3MIFKMONPC1
SCHEMBL284286 0.85 ASIC3 (0.71) ASIC3MIFKMONPC1RAB9A
SCHEMBL22376349 0.83 KMO (0.59) ASIC3MIFKMOCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9932522-B2 Electrochromic compound, electrochromic composition, display element, and dimming element RICOH COMPANY, LTD. (JP) 2018-04-03 US disclosed
US-9932522-B2 Electrochromic compound, electrochromic composition, display element, and dimming element RICOH COMPANY, LTD. (JP) 2018-04-03 US disclosed
US-20170226413-A1 ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, DISPLAY ELEMENT, AND DIMMING ELEMENT RICOH COMPANY, LTD. (JP) 2017-08-10 US disclosed
US-20170226413-A1 ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, DISPLAY ELEMENT, AND DIMMING ELEMENT RICOH COMPANY, LTD. (JP) 2017-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170226413-A1 ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, DISPLAY ELEMENT, AND DIMMING ELEMENT EMC2, EMC1, KCNB2 NOTUM 4641/4885ASIC3 1131/4885MIF 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.